Kudo H, Ohshio G, Ogawa K, Kim Y C, Wakatsuki Y, Nakashima Y, Yamabe H, Inada M
Department of Geriatric Medicine, Faculty of Medicine, Kyoto University, Japan.
J Clin Pathol. 1988 Mar;41(3):320-3. doi: 10.1136/jcp.41.3.320.
To evaluate whether the increase in serum transcobalamin I, seen in patients with carcinoma, is caused by synthesis of R-binder to tumour cells, the distribution of vitamin B12 R-binder in 125 malignant growths of the digestive tract was studied. Positive staining for R-binder with immunoperoxidase was observed in 85 (70%) carcinomas. Positive staining for R-binder was observed in all four cholangiocarcinomas studied, but was absent in nine hepatocellular carcinomas. These findings suggest that determination of R-binder in liver tumours may be of some value in differentiating hepatocellular carcinomas and cholangiocarcinoma, and that synthesis of R-binder by tumour cells causes an increase in serum transcobalamin I.
为评估癌症患者血清转钴胺素I升高是否由R结合蛋白与肿瘤细胞的合成所致,研究了125例消化道恶性肿瘤中维生素B12 R结合蛋白的分布。85例(70%)癌组织中观察到免疫过氧化物酶对R结合蛋白的阳性染色。在所研究的4例胆管癌中均观察到R结合蛋白的阳性染色,但9例肝细胞癌中未观察到。这些发现提示,测定肝脏肿瘤中的R结合蛋白可能对鉴别肝细胞癌和胆管癌有一定价值,且肿瘤细胞合成R结合蛋白会导致血清转钴胺素I升高。